Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Needham & Company LLC Issues Positive Forecast for Vir Biotechnology (NASDAQ:VIR) Stock Price
Vir Biotechnology Inc (VIR) (Q3 2026) Earnings Call Highlights: Hepatitis Delta Data on Deck ...
Narrower Losses Could Be A Game Changer For Vir Biotechnology (VIR)
What Vir Biotechnology (VIR) Said on Its Q3 Earnings Call - Daily Political
Vir Biotechnology (NASDAQ:VIR) Releases Quarterly Earnings Results, Beats Expectations By $0.18 EPS
Insider Selling: Vir Biotechnology (NASDAQ:VIR) EVP Sells $15,216.19 in Stock
Vir Biotechnology (NASDAQ:VIR) EVP Sells $26,717.70 in Stock - Stock Observer
Vir Biotechnology (NASDAQ:VIR) Stock: Insider Verneuil Vanina De Sells 1,343 Shares - Daily Political
Head-To-Head Review: Vir Biotechnology (NASDAQ:VIR) & BioCryst Pharmaceuticals (NASDAQ:BCRX) - Daily Political
Vir Biotechnology (NASDAQ:VIR) Reaches New 52-Week High - Should You Buy?
Vir Biotechnology (NASDAQ:VIR) Shares Gap Down - What's Next?
Gilead Cancer Deal Could Be A Game Changer For Vir Biotechnology (VIR)
Vir Biotechnology (NASDAQ:VIR) Shares Gap Down - Here's What Happened - Stock Observer
Vir Biotechnology (VIR) Projected to Post Quarterly Earnings on Wednesday
Vir Biotechnology (NASDAQ:VIR) Shares Cross Above 50-Day Moving Average - What's Next?
Is Vir Biotechnology (VIR) Undervalued On Its Gilead Oncology Deal?
Comparing Vir Biotechnology (NASDAQ:VIR) and REGENXBIO (NASDAQ:RGNX) - Markets Daily
Vir Biotechnology, Inc. (VIR) - What Are Investment Firms Thinking About This Stock?
Hepatitis B Virus (HBV) Infection Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Ascletis Pharma, Shanghai HEP Pharma, Romark Lab, GSK | ABNewswire
Vir Biotechnology (NASDAQ:VIR) & REGENXBIO (NASDAQ:RGNX) Head-To-Head Survey - Stock Observer
Did Cancer Drug Partnership Just Shift Gilead's (GILD) Investment Narrative? - Simply Wall St News
Could Vir Biotechnology (VIR) Be Above Fair Value After Recent Pipeline News?
I'm Taking Out Some 'Insurance' on My Portfolio With These 2 Stocks
What Could Gilead Sciences (GILD) New Solid Tumor Partnership Mean For Oncology?
Gilead Sciences, Inc. $GILD Stake Trimmed by Curated Wealth Partners LLC - Zolmax
Vir Biotechnology and Gilead Sciences Forge $1.88 Billion Collaboration for Solid Tumor Cancer Therapies, ETPharma
Vir partners with Gilead in $1.8B+ deal for T-cell engagers
Verastem focuses on KRAS G12D therapy, reports 41% ORR in PDAC
Vir Biotechnology Partners With Gilead On Next-Generation Cancer Immunotherapy Programs
Vir Biotechnology Shares Jump on Gilead Cancer Collaboration | Morningstar
Vir CEO sees 'opportunity to do more deals' after striking $1.9B Gilead pact for dual-masked TCEs
Vir Biotechnology (NASDAQ:VIR) Shares Gap Up - What's Next? - Daily Political
Is FDA Fast Track Status Altering The Investment Case For Vir Biotechnology (VIR)?
Is Vir Biotechnology (VIR) Cheap On Fast Track News And SOLSTICE Data Hopes?
Vir Biotechnology (NASDAQ:VIR) Hits New 52-Week High - Here's What Happened
Vir Biotechnology (NASDAQ:VIR) Shares Down 6.5% - Time to Sell? - Stock Observer
Vir Biotechnology (NASDAQ:VIR) Shares Climb 6.1% - Here's Why - Stock Observer
Vir Biotechnology (NASDAQ:VIR) Shares Down 6.5% - Here's What Happened
Vir Biotechnology (NASDAQ:VIR) Stock Bumped Down to "Strong Sell" by Zacks Research - Markets Daily
Vir Biotechnology (NASDAQ:VIR) Cut to "Strong Sell" at Zacks Research
How Upcoming SOLSTICE Phase 2 HDV Data Could Shape Vir Biotechnology's (VIR) Investment Narrative
VIR Maintains by HC Wainwright & Co. -- Price Target Raised to $
Vir Biotechnology (NASDAQ:VIR) Given New $22.00 Price Target at HC Wainwright
VirBiotechnology News
Micron Stock Price Forecast 2026–2030: Can AI Memory Demand Reverse a 26% Week-to-Date Sell-Off?
Arm Holdings Stock Forecast 2026–2030: Can Data-Center Royalty Growth Drive a Recovery?
Boeing Stock Forecast 2026–2030: Can a Record $745 Billion Backlog Reverse BA’s 11% Earnings Sell-Off?
Latest news
Show more
Nasdaq Falls 5.52% as AI Selloff Drives S&P 500’s Worst Day Since April 2025
Nvidia Stock Falls 9.26% to $181.60 as Data Center Concerns Hit AI Shares
AppLovin Stock Soars 31% as Record Revenue and a $3.2 Billion Buyback Defy the AI Sell-Off
Oil Price Today Rebounds Toward $100 as New Tanker Attacks Revive Supply Fears
Tesla Plans Cybertruck Wind-Down in Texas as Cybercab Takes Priority
